REPORT ID 8226

EMEA (Europe, Middle East and Africa) Pneumococcal Vaccines Market Report 2017

Publish Date
7-Nov-17
Pages
128
Format
Electronic (PDF)

In this report, the EMEA Pneumococcal Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Pneumococcal Vaccines for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Pneumococcal Vaccines market competition by top manufacturers/players, with Pneumococcal Vaccines sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Sanofi
    GSK
    Merck
    Eli Lilly
    AstraZeneca
    Abera
    S K Chemicals
    Beijing Minhai Biotechnology
    Baxter
    Biken
    Celgene Corporation
    Panacea Biotec
    Serum Institute of India
    Genentech
    Genocea Biosciences
    ImmunoBiology
    Lupin
    Nuron Biotech
    Biogen
    Valneva Austria
    Sinovac

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    PPSV 23
    PCV 7/13
    PCV 10

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    For Infants
    For Children (2-10)
    For Person (10-64)
    For The Old (?65)

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Pneumococcal Vaccines Market Report 2017
1 Pneumococcal Vaccines Overview
    1.1 Product Overview and Scope of Pneumococcal Vaccines
    1.2 Classification of Pneumococcal Vaccines
        1.2.1 EMEA Pneumococcal Vaccines Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Pneumococcal Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 PPSV 23
        1.2.4 PCV 7/13
        1.2.5 PCV 10
    1.3 EMEA Pneumococcal Vaccines Market by Application/End Users
        1.3.1 EMEA Pneumococcal Vaccines Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 For Infants
        1.3.3 For Children (2-10)
        1.3.4 For Person (10-64)
        1.3.5 For The Old (?65)
    1.4 EMEA Pneumococcal Vaccines Market by Region
        1.4.1 EMEA Pneumococcal Vaccines Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Pneumococcal Vaccines (2012-2022)
        1.5.1 EMEA Pneumococcal Vaccines Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Pneumococcal Vaccines Revenue and Growth Rate (2012-2022)

2 EMEA Pneumococcal Vaccines Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Pneumococcal Vaccines Market Competition by Players/Manufacturers
        2.1.1 EMEA Pneumococcal Vaccines Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Pneumococcal Vaccines Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Pneumococcal Vaccines Sale Price by Players (2012-2017)
    2.2 EMEA Pneumococcal Vaccines (Volume and Value) by Type/Product Category
        2.2.1 EMEA Pneumococcal Vaccines Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Pneumococcal Vaccines Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Pneumococcal Vaccines Sale Price by Type (2012-2017)
    2.3 EMEA Pneumococcal Vaccines (Volume) by Application
    2.4 EMEA Pneumococcal Vaccines (Volume and Value) by Region
        2.4.1 EMEA Pneumococcal Vaccines Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Pneumococcal Vaccines Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Pneumococcal Vaccines Sales Price by Region (2012-2017)

3 Europe Pneumococcal Vaccines (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Pneumococcal Vaccines Sales and Value (2012-2017)
        3.1.1 Europe Pneumococcal Vaccines Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Pneumococcal Vaccines Revenue and Growth Rate (2012-2017)
    3.2 Europe Pneumococcal Vaccines Sales and Market Share by Type
    3.3 Europe Pneumococcal Vaccines Sales and Market Share by Application
    3.4 Europe Pneumococcal Vaccines Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Pneumococcal Vaccines Sales Volume by Countries (2012-2017)
        3.4.2 Europe Pneumococcal Vaccines Revenue by Countries (2012-2017)
        3.4.3 Germany Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
        3.4.4 France Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
        3.4.5 UK Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
        3.4.6 Russia Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
        3.4.7 Italy Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Pneumococcal Vaccines Sales and Growth Rate (2012-2017)

4 Middle East Pneumococcal Vaccines (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Pneumococcal Vaccines Sales and Value (2012-2017)
        4.1.1 Middle East Pneumococcal Vaccines Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Pneumococcal Vaccines Revenue and Growth Rate (2012-2017)
    4.2 Middle East Pneumococcal Vaccines Sales and Market Share by Type
    4.3 Middle East Pneumococcal Vaccines Sales and Market Share by Application
    4.4 Middle East Pneumococcal Vaccines Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Pneumococcal Vaccines Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Pneumococcal Vaccines Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
        4.4.4 Israel Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
        4.4.5 UAE Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
        4.4.6 Iran Pneumococcal Vaccines Sales and Growth Rate (2012-2017)

5 Africa Pneumococcal Vaccines (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Pneumococcal Vaccines Sales and Value (2012-2017)
        5.1.1 Africa Pneumococcal Vaccines Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Pneumococcal Vaccines Revenue and Growth Rate (2012-2017)
    5.2 Africa Pneumococcal Vaccines Sales and Market Share by Type
    5.3 Africa Pneumococcal Vaccines Sales and Market Share by Application
    5.4 Africa Pneumococcal Vaccines Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Pneumococcal Vaccines Sales Volume by Countries (2012-2017)
        5.4.2 Africa Pneumococcal Vaccines Revenue by Countries (2012-2017)
        5.4.3 South Africa Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Pneumococcal Vaccines Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Pneumococcal Vaccines Sales and Growth Rate (2012-2017)

6 EMEA Pneumococcal Vaccines Manufacturers/Players Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Pneumococcal Vaccines Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Sanofi
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Pneumococcal Vaccines Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sanofi Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 GSK
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Pneumococcal Vaccines Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 GSK Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Merck
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Pneumococcal Vaccines Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Merck Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Eli Lilly
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Pneumococcal Vaccines Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Eli Lilly Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 AstraZeneca
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Pneumococcal Vaccines Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 AstraZeneca Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Abera
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Pneumococcal Vaccines Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Abera Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 S K Chemicals
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Pneumococcal Vaccines Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 S K Chemicals Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Beijing Minhai Biotechnology
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Pneumococcal Vaccines Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Beijing Minhai Biotechnology Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Baxter
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Pneumococcal Vaccines Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Baxter Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Biken
    6.12 Celgene Corporation
    6.13 Panacea Biotec
    6.14 Serum Institute of India
    6.15 Genentech
    6.16 Genocea Biosciences
    6.17 ImmunoBiology
    6.18 Lupin
    6.19 Nuron Biotech
    6.20 Biogen
    6.21 Valneva Austria
    6.22 Sinovac

7 Pneumococcal Vaccines Manufacturing Cost Analysis
    7.1 Pneumococcal Vaccines Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Pneumococcal Vaccines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Pneumococcal Vaccines Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Pneumococcal Vaccines Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Pneumococcal Vaccines Market Forecast (2017-2022)
    11.1 EMEA Pneumococcal Vaccines Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Pneumococcal Vaccines Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Pneumococcal Vaccines Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Pneumococcal Vaccines Price and Trend Forecast (2017-2022)
    11.2 EMEA Pneumococcal Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Pneumococcal Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Pneumococcal Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Pneumococcal Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Pneumococcal Vaccines Sales Forecast by Type (2017-2022)
    11.7 EMEA Pneumococcal Vaccines Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer